[go: up one dir, main page]

WO2003105990A3 - FILTER MATERIAL FOR TOXINS, BACTERIA, VIRUSES AND OTHER HARMFUL PHYSIOLOGICAL SUBSTANCES - Google Patents

FILTER MATERIAL FOR TOXINS, BACTERIA, VIRUSES AND OTHER HARMFUL PHYSIOLOGICAL SUBSTANCES Download PDF

Info

Publication number
WO2003105990A3
WO2003105990A3 PCT/EP2003/005957 EP0305957W WO03105990A3 WO 2003105990 A3 WO2003105990 A3 WO 2003105990A3 EP 0305957 W EP0305957 W EP 0305957W WO 03105990 A3 WO03105990 A3 WO 03105990A3
Authority
WO
WIPO (PCT)
Prior art keywords
filter material
toxins
viruses
bacteria
physiological substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2003/005957
Other languages
German (de)
French (fr)
Other versions
WO2003105990A2 (en
Inventor
Hans-Uwe Wolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to AU2003245917A priority Critical patent/AU2003245917A1/en
Priority to EP03737999A priority patent/EP1526910A2/en
Publication of WO2003105990A2 publication Critical patent/WO2003105990A2/en
Publication of WO2003105990A3 publication Critical patent/WO2003105990A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
    • B01J20/3204—Inorganic carriers, supports or substrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
    • B01J20/3206—Organic carriers, supports or substrates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/20—Pathogenic agents
    • A61M2202/203—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/20—Pathogenic agents
    • A61M2202/206—Viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to a filter material for toxins, bacteria, viruses, and other harmful physiological substances, which can be used during hemoperfusion in order to rid physiological liquids of such harmful substances. Said filter material is based on compounds belonging to the class of calixarenes and resorcinarenes. The physiological liquids can be blood, plasma, or urine, for example.
PCT/EP2003/005957 2002-06-12 2003-06-06 Filter material for toxins, bacteria, viruses, and other harmful physiological substances Ceased WO2003105990A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2003245917A AU2003245917A1 (en) 2002-06-12 2003-06-06 Filter material for toxins, bacteria, viruses, and other harmful physiological substances
EP03737999A EP1526910A2 (en) 2002-06-12 2003-06-06 Filter material for toxins, bacteria, viruses, and other harmful physiological substances

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10226099A DE10226099A1 (en) 2002-06-12 2002-06-12 Filter material for toxins, bacteria, viruses and other physiological pollutants
DE10226099.0 2002-06-12

Publications (2)

Publication Number Publication Date
WO2003105990A2 WO2003105990A2 (en) 2003-12-24
WO2003105990A3 true WO2003105990A3 (en) 2004-04-01

Family

ID=29718988

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/005957 Ceased WO2003105990A2 (en) 2002-06-12 2003-06-06 Filter material for toxins, bacteria, viruses, and other harmful physiological substances

Country Status (4)

Country Link
EP (1) EP1526910A2 (en)
AU (1) AU2003245917A1 (en)
DE (1) DE10226099A1 (en)
WO (1) WO2003105990A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8556085B2 (en) 2010-11-08 2013-10-15 Stuart Bogle Anti-viral device

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992012709A1 (en) * 1991-01-29 1992-08-06 Genelabs Technologies, Inc. Aryl macrocyclic compositions for treating viral infections
WO1994003164A1 (en) * 1992-08-06 1994-02-17 Genelabs Technologies, Inc. Inhibition and treatment of infection by enveloped virus with calix(n) arene compounds
JPH11209740A (en) * 1998-01-19 1999-08-03 Kurita Water Ind Ltd Separating agent for halogenated ethylene compounds
US6136071A (en) * 1996-02-28 2000-10-24 Transdiffusia S.A. Process for the recovery of volatile low molecular compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989008092A1 (en) * 1988-02-29 1989-09-08 The Flinders University Of South Australia Removal of organic compounds from fluids
AU1545395A (en) * 1994-01-24 1995-08-08 Stephen J. Harris Calixarene-based compounds having antibacterial, antifungal, anticancer-hiv activity

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992012709A1 (en) * 1991-01-29 1992-08-06 Genelabs Technologies, Inc. Aryl macrocyclic compositions for treating viral infections
WO1994003164A1 (en) * 1992-08-06 1994-02-17 Genelabs Technologies, Inc. Inhibition and treatment of infection by enveloped virus with calix(n) arene compounds
US6136071A (en) * 1996-02-28 2000-10-24 Transdiffusia S.A. Process for the recovery of volatile low molecular compounds
JPH11209740A (en) * 1998-01-19 1999-08-03 Kurita Water Ind Ltd Separating agent for halogenated ethylene compounds

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
A. DONDONI ET AL, CHEMISTRY - A EUROPEAN JOURNAL, vol. 3, no. 11, 1997, pages 1774 - 1782, XP001091340 *
CHEMICAL ABSTRACTS, vol. 131, no. 10, 6 September 1999, Columbus, Ohio, US; abstract no. 131813, XP002263940 *
DATABASE CAPLUS AMERICAN CHEMICAL SOCIETY; 1999, XP002263941, retrieved from STN Database accession no. 1999:481646 *
M.H.B GROTE GANSEY ET AL, BIOCONJUGATE CHEM., vol. 10, no. 4, 1999, pages 613 - 623, XP000831957 *
R. AZHARI ET AL, JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, vol. 21, no. 1, 1987, pages 25 - 41, XP001091341 *

Also Published As

Publication number Publication date
AU2003245917A8 (en) 2003-12-31
DE10226099A1 (en) 2004-01-08
AU2003245917A1 (en) 2003-12-31
WO2003105990A2 (en) 2003-12-24
EP1526910A2 (en) 2005-05-04

Similar Documents

Publication Publication Date Title
Singh et al. Photochemical treatment of plasma with amotosalen and long‐wavelength ultraviolet light inactivates pathogens while retaining coagulation function
Borkow et al. Neutralizing viruses in suspensions by copper oxide-based filters
Mattle et al. Impact of virus aggregation on inactivation by peracetic acid and implications for other disinfectants
ATE325613T1 (en) APHERESIS OF LEUKOCYTES FROM BLOOD FOR THE TREATMENT OF HIV
Roth et al. Nanofiltration as a robust method contributing to viral safety of plasma‐derived therapeutics: 20 yearsʼ experience of the plasma protein manufacturers
DK0431129T3 (en) Methods for inactivating viruses in virus-contaminated pharmaceutical compositions
El-Ekiaby et al. Minipool caprylic acid fractionation of plasma using disposable equipment: a practical method to enhance immunoglobulin supply in developing countries
DE69533942D1 (en) TREATMENT OF SOLUTIONS OF RED BLOOD BODIES WITH ANTIVIRAL ACTIVE SUBSTANCES
WO2002089731A3 (en) Agents for treatment of hcv and methods of use
ATE378402T1 (en) DEVICE AND METHOD FOR PRODUCING AUTOLOGUE THROMBIN SERUM
EP1127170A4 (en) HUMAN MONOCLONAL ANTIBODIES TO HUMAN PAN-HEPATITIS C VIRUS
BR0013576A (en) Microbiological water filter
ATE405279T1 (en) IMMOBILIZATION AND STABILIZATION OF VIRUSES
WO2008036899A3 (en) Methods for removing viral contaminants during protein purification
WO2010047830A3 (en) Agents for hcv treatment
TR200103305T2 (en) Method for removing nano-sized pathogens from liquids.
ATE514470T1 (en) FILTER FOR REMOVAL OF LEUKOCYTES FROM BLOOD PRODUCTS
ATE403712T1 (en) USE OF POLYMERS CONTAINING THERMOPLASTIC POLYMERS AS FILTER AIDS AND/OR STABILIZING AGENTS
WO2001097824A3 (en) Use of phyllanthus constituents for treating or preventing infections caused by flaviviridae
WO2003105990A3 (en) FILTER MATERIAL FOR TOXINS, BACTERIA, VIRUSES AND OTHER HARMFUL PHYSIOLOGICAL SUBSTANCES
DE60032915D1 (en) GALLIUM COMPLEXES OF 3-HYDROXY-4-PYRONES FOR THE TREATMENT OF INFECTIONS CAUSED BY INTRA-CELLULAR PROCYNOTES, DNA AND RETRO VIRUSES
BR0115970A (en) Use of a disrupted membrane binding compound, compound, method for detecting disrupted membranes in biological cells, pharmaceutical composition, filter device for cleaning a body fluid from circulating cells or cell structures having disrupted membranes, extracorporeal circulation apparatus for clearing blood from circular cells or cell structures having disturbed membranes, and methods for removing pm-containing cells or pm-containing structures from a body fluid, for treating or preventing a disease, and for treating cancer
Elkington et al. Filter sterilization of highly infectious samples to prevent false negative analysis of matrix metalloproteinase activity
IT1292798B1 (en) STERILE SYSTEM AND PROCEDURE FOR FILTRATION OF BIOLOGICAL OR MEDICAL LIQUIDS, IN PARTICULAR OF BLOOD OR BLOOD COMPONENTS.
ATE460947T1 (en) METHOD FOR STERILIZING BIOLOGICAL PREPARATIONS

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003737999

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003737999

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP